Full Text
PSY114 - COST-EFFECTIVENESS OF VEDOLIZUMAB COMPARED WITH CONVENTIONAL THERAPY IN PATIENTS WITH CROHN’S DISEASE IN THE UNITED KINGDOM (UK)

Abstract

Authors

R.E. Robson A. Vanoli K. Tolley

Back to Volume 21, Supplemental S3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×